Biomarkers of CIDP in patients with diabetes or CMT1 Academic Article uri icon

Overview

MeSH Major

  • Biomarkers
  • Charcot-Marie-Tooth Disease
  • Diabetic Neuropathies
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

abstract

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease that targets the myelin sheaths in peripheral nerves. Primary demyelination can be detected by electrodiagnostic studies or nerve biopsy, but these do not distinguish between demyelination resulting from CIDP or from non-inflammatory causes such as diabetes or Charcot-Marie-Tooth type I. Consequently, the diagnosis of CIDP in such patients is often missed. Studies are needed to establish electrodiagnostic criteria for CIDP in patients with diabetes, and to identify biomarkers that distinguish between inflammatory and non-inflammatory causes of demyelinating neuropathy.

publication date

  • June 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1529-8027.2011.00299.x

PubMed ID

  • 21696491

Additional Document Info

start page

  • 14

end page

  • 7

volume

  • 16

number

  • SUPPL. 1